T cell epitopes suitable for detection, isolation and expansion of tumor-reactive T cells from patients. T cell epitope. T cell epitopes derived from melanoma antigens. This strategy is generally applicable to target antigens of other tumor entities and to different HLA class II molecules even without prior characterization of their peptide binding motives
The recent characterization of MHC-displayed tumor-associated anti-gens that recognize effector cell...
Though it is understood that T-cells are a critical component of the immune system’s ability to dest...
A number of cell surface molecules with specificity to tumour cells have been identified and monoclo...
Background: As tumor antigen-specific CD4+ T cells can mediate strong therapeutic anti-tumor respons...
Adoptive transfer of antigen-specific T-cells has shown therapeutic successes in the treatment of tu...
The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrat...
Previous attempts to treat human malignancies by adoptive transfer of tumor-specific CTLs have been ...
Altered peptide antigens that enhance T-cell immunogenicity have been used to improve peptide-based ...
Recent studies in mouse models have suggested that genetic transfer of tumor antigen-specific high a...
CD4(+) T cells modulate the magnitude and durability of CTL responses in vivo, and may serve as effe...
Reports have shown that activation of tumor-specific CD4+ helper T (Th) cells is crucial for effecti...
Reports have shown that activation of tumor-specific CD4(+) helper T (Th) cells is crucial for effec...
Abstract HLA-A2.1-associated peptides, extracted from human melanoma cells, were used to study epito...
Immune tolerance of dominant tumor-associated antigens presents a particular challenge in developing...
Background: Current peptide vaccines may select suboptimal antigen-specific T-cells from polyclonal ...
The recent characterization of MHC-displayed tumor-associated anti-gens that recognize effector cell...
Though it is understood that T-cells are a critical component of the immune system’s ability to dest...
A number of cell surface molecules with specificity to tumour cells have been identified and monoclo...
Background: As tumor antigen-specific CD4+ T cells can mediate strong therapeutic anti-tumor respons...
Adoptive transfer of antigen-specific T-cells has shown therapeutic successes in the treatment of tu...
The T cells of the immune system can target tumors and clear solid cancers following tumor-infiltrat...
Previous attempts to treat human malignancies by adoptive transfer of tumor-specific CTLs have been ...
Altered peptide antigens that enhance T-cell immunogenicity have been used to improve peptide-based ...
Recent studies in mouse models have suggested that genetic transfer of tumor antigen-specific high a...
CD4(+) T cells modulate the magnitude and durability of CTL responses in vivo, and may serve as effe...
Reports have shown that activation of tumor-specific CD4+ helper T (Th) cells is crucial for effecti...
Reports have shown that activation of tumor-specific CD4(+) helper T (Th) cells is crucial for effec...
Abstract HLA-A2.1-associated peptides, extracted from human melanoma cells, were used to study epito...
Immune tolerance of dominant tumor-associated antigens presents a particular challenge in developing...
Background: Current peptide vaccines may select suboptimal antigen-specific T-cells from polyclonal ...
The recent characterization of MHC-displayed tumor-associated anti-gens that recognize effector cell...
Though it is understood that T-cells are a critical component of the immune system’s ability to dest...
A number of cell surface molecules with specificity to tumour cells have been identified and monoclo...